Dothan Alabama is a clinical research site located in Dothan, Alabama, United States 36301.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Dothan Alabama has participated in 1 clinical trials.
Therapeutic areas: Neurotrophic Keratopathy.
Sponsors: Oyster Point Pharma, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dothan Alabama has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dothan Alabama has 1 clinical trials on record. Their work covers Neurotrophic Keratopathy.
Dothan Alabama has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.